Jane Elizabeth Keyser

CIK: 0001959756

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NRXS

Neuraxis, INC

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

NRXS
Neuraxis, INC
Aug 13, 2026
Award(A)
Direct
26.1K shares at avg. $6.28$164K
NRXS
Neuraxis, INC
Jan 22, 2026
Award(A)
Direct
21.6K shares at avg. $4.63$100K
NRXS
Neuraxis, INC
Jan 17, 2025
Award(A)
Direct
13.2K shares at avg. $2.85$37K

		Type	Shares	Price		Ownership
Aug 13, 2026	NRXS Neuraxis, INC	Award(A)	26,073	$6.28	$163,738	Direct
Jan 22, 2026	NRXS Neuraxis, INC	Award(A)	21,598	$4.63	$99,999	Direct
Jan 17, 2025	NRXS Neuraxis, INC	Award(A)	13,157	$2.85	$37,497	Direct

1-3 of 3 transactions

About Keyser Jane Elizabeth

Keyser Jane Elizabeth (SEC CIK 0001959756) files insider reports with the SEC as Director of Neuraxis, INC (NRXS).

Signal8 holds 3 ownership filings by Keyser Jane Elizabeth, all Form 4s, filed between Sep 10, 2025 and Aug 17, 2026. Those filings report 3 transactions, from Jan 17, 2025 to Aug 13, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Keyser Jane Elizabeth's filings is in CARMEL, IN.

Recent filings by Keyser Jane Elizabeth

Aug 13, 2026: Grant or award of NRXS shares (Form 4, code A).
Jan 22, 2026: Grant or award of NRXS shares (Form 4, code A).
Jan 17, 2025: Grant or award of NRXS shares (Form 4, code A).

Other insiders filing for Neuraxis, INC (NRXS)

Carrico Brian Allen, Chief Executive Officer
Carrico Thomas Joeseph, CRO, CCO, CPO
Henrichs Timothy Robert, Chief Financial Officer
Blanchard Craig Thomas, Chief Commercial Officer
Miranda Adrian, CMO, SVP Science & Tech
Watkins Bradley Mitchell, Director

How to read Form 4 transaction codes